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Simple Summary: Night shift work (NSW) may disturb circadian rhythms. This could influence
the risk of breast cancer (BC), but research papers have reported conflicting results. We reviewed,
summarized, and combined the results of those studies that measured the effect of long-term
nightshift work (≥15 years of NSW) in BC with special attention to menopausal status and time since
retirement age. Women with long-term NSW had 13% more risk of BC than women without NSW.
Postmenopausal women showed no increased risk, while premenopausal women had a 27% higher
risk. Women with a higher probability of recent long-term NSW (women under retirement age) had
a 23% higher risk than women without NSW. We concluded that long-term NSW may increase BC
risk, especially in women before menopause or shortly after NSW discontinuation.
Abstract: This systematic review discusses long-term NSW and female BC risk, with special at-
tention to differences between pre- and postmenopausal BC, to test the association with recent
NSW. The review follows PRISMA guidelines (Prospero registry: CRD42018102515). We searched
PubMed, Embase, and WOS for case–control, nested case–control, and cohort studies addressing
long-term NSW (≥15 years) as risk exposure and female BC as outcome until 31 December 2020.
Risk of bias was evaluated with the Newcastle–Ottawa scale. Eighteen studies were finally in-
cluded (eight cohorts; five nested case–control; five case–control). We performed meta-analyses
on long-term NSW and BC risk; overall and by menopausal status; a subanalysis on recent long-
term NSW, based on studies involving predominantly women below retirement age; and a dose–
response meta-analysis on NSW duration. The pooled estimate for long-term NSW and BC was
1.13 (95%CI = 1.01–1.27; 18 studies, I2 = 56.8%, p = 0.002). BC risk increased 4.7% per 10 years of
NSW (95%CI = 0.94–1.09; 16 studies, I2 = 33.4%, p = 0.008). The pooled estimate for premenopausal
BC was 1.27 (95%CI = 0.96–1.68; six studies, I2 = 32.0%, p = 0.196) and for postmenopausal BC 1.05
(95%CI = 0.90–1.24, I2 = 52.4%; seven studies, p = 0.050). For recent long-term exposure, the pooled
estimate was 1.23 (95%CI = 1.06–1.42; 15 studies; I2 = 48.4%, p = 0.018). Our results indicate that
long-term NSW increases the risk for BC and that menopausal status and time since exposure might
be relevant.
Keywords: nightshift work; breast cancer; recent exposure; meta-analysis; menopausal status;
occupational exposure; retirement age
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1. Introduction
Many women’s working lives are characterized by some degree of night work, either
as permanent shifts or as shifts within rotating work schedules. The European Union
defines “night time” as any period of seven or more hours- as defined by national law,
which includes the period between midnight and 5.00 a.m. [1]. Two large surveys provide
information about the prevalence of night work in western societies [2,3]. According to
the “Sixth European Working Conditions Survey” (2015), 14% of working women carried
out night work [3], while in the “American Time Use Survey” of the US Bureau of Labor
Statistics (2017/2018), 3.9% of working women reported night work, 2.1% rotating shifts,
and 2.5% irregular shifts [2].
Humans share with other organisms the fundamental properties of a biological circa-
dian system [4]. Night work has been studied as a possible risk factor for several diseases
because physiological functions such as temperature and glucose homeostasis, hormone
secretion, and immunological functions follow endogenous circadian rhythms [5]. These
rhythms are controlled by the central circadian pacemaker, located in the suprachiasmatic
nucleus of the hypothalamus [4]. Cellular circadian clocks generate roughly 24 h oscilla-
tions in the function of thousands of genes, allowing the organism to anticipate regular
changes, to optimize energy, and to temporally separate incompatible processes [6]. As
light is the most important stimulus that may reset circadian rhythms daily, by direct
neuronal connections between the retina and the pacemaker, mistimed exposure to artifi-
cial light, usual in nightshift work (NSW), can cause important changes in the phase and
amplitude of circadian rhythms, with deleterious effects in health [7].
In 2019, the International Agency for Research on Cancer, confirming a previous
evaluation, classified NSW as probably carcinogenic to humans (Group 2A on a scale with
a range from 1 “carcinogenic to humans” to 3 “not classifiable as to its carcinogenicity to
humans”). Its decision was based on limited evidence from studies in humans and strong
evidence from experimental findings, which showed its effects in immunosuppression,
chronic inflammation, and cell proliferation [8]. The tumors with positive associations with
NSW were mainly breast, prostate, and colorectal cancer [8].
This issue has awakened enormous interest, given the global burden of breast cancer
(BC) [9] and the considerable prevalence of NSW. Unfortunately, the results of individual
epidemiological studies have so far been inconsistent. Additionally, a number of meta-
analyses have come to different conclusions [10–12]. One factor that could be related to the
inconsistency of results in observational studies is the duration of NSW. Most of the studies
that evaluated different categories of duration observed an elevated BC risk for long-term
NSW (≥15/≥20 years) [13–19], in contrast to the moderate [16,17,19,20] or absent excess
risk observed for shorter exposures (<15 years) [12,14,15,18,21,22].
Another important issue that might help to understand the inconsistent results is
the possible role of menopausal status in this presumptive association. Pre- and post-
menopausal breast cancer have different temporal trends, can differ in their molecular
profile, and even have opposite relationships with some of the known risk factors for this
tumor, such as obesity (i.e., obese women have a lower risk of premenopausal cancer and
higher risk of postmenopausal tumors than women of normal weight) [23–25].
Another possible reason for these discrepancies might be related to a critical point:
the lag time between the last NSW exposure and the end of follow-up for the occurrence
of BC in some cohort studies [26,27]. Some authors have hypothesized that NSW may
act essentially as a promoter in BC; if that were the case, when NSW exposure ceases, the
associated BC risk increase should wane [13,28], while the increased risk associated with
NSW should be mostly visible in recently exposed women. This pattern of decreasing
risk since the cessation of exposure has also been proposed for the suggested association
between NSW and other tumors [29]. As far as we know, no meta-analysis has focused on
this interesting issue, although a pooled analysis of case–control studies found a higher
premenopausal BC risk in women with recent exposure than in those who had stopped
night work more than two years before [30].
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For this reason, we carried out an overall meta-analysis of observational studies on
long-term NSW and BC, a dose–response meta-analysis, and a sub-meta-analysis on recent
long-term NSW. Therefore, this meta-analysis allows exploring both factors, the duration of
NSW, and recent exposure in BC risk assessment. Given the possible biological differences
between pre- and postmenopausal BC associated with long-term NSW, we also carried out
subgroup analyses by menopausal status.
2. Materials and Methods
2.1. Literature Search and Eligibility Criteria
This review was conducted according to the PRISMA guidelines [31]. The protocol
is registered in PROSPERO [32] (CRD42018102515), where methodological details can be
consulted. We updated the search for original articles in PubMed/MEDLINE, Embase,
and the Web of Science, using the terms (“nightshift” OR “night shift” OR “shiftwork”
OR “shift work” OR “nightwork”) combined with “Breast cancer” from inception until
31 December 2020.
Our final search strategy was complemented with a manual search based on the
references cited in the papers selected for full-text review. Additionally, we also went
through the reference lists of the published meta-analyses. We took into consideration
results in English, Spanish, German, or French. For this review, we considered eligible
all original case–control, nested case–control, and cohort studies that compared, as risk
exposure, long-term NSW (defined as ≥15 years) to having never done NSW. These studies
had to provide original data and to have female BC risk as the outcome.
2.2. Data Extraction
Two members of our research team (A.P., C.S.) performed the original abstract/title
screening, the full-text review, and the data extraction. In case of doubts or disagreements,
a third author’s opinion (B.P.G.) allowed reaching a consensus. In the presence of diverse
options of risk estimators, we used preferentially those including NSW exposure between
12.00 p.m. and 3.00 a.m. In cohort studies with several reports, we used the latest update if
there were new cases or if the analysis was improved in terms of methodology. With respect
to exposure ascertainment, we prioritized self-reported individual data over job-exposure
matrix estimations. According to our inclusion criteria, we selected studies providing
data corresponding to a minimum of 15 years of NSW, without restricting the exposure
to a minimum number of nights per month. Authors from two studies were contacted to
request additional data about the definition of nonexposure (information received) and
mean age at BC diagnosis (information finally not available).
2.3. Risk of Bias Assessment of Individual Studies (Newcastle–Ottawa Scale)
The risk of bias of each study was evaluated by two researchers (A.P., C.S.) using the
Newcastle–Ottawa scale (NOS) [33], an eight-item scale developed to assess the quality
of nonrandomized studies for meta-analyses with a maximum punctuation of nine stars
(see Table S1). It assigns four stars to items related to selection and representativeness of
the study groups. Another three stars correspond to the evaluation of the ascertainment
of the exposure or the outcome of interest for case–control or cohort studies, respectively,
and some of these items require operative definitions. In this case, for cohort studies, we
assigned one star to those with at least 15 years of follow-up (15 years of NSW exposure
does not determine the follow-up time, since exposure may be assessed retrospectively)
and another to those with a difference ≤15% in the proportion of subjects lost to follow-up
between exposed and unexposed. For case–control studies, we gave one star to those
with differences ≤15% in nonresponse rates between cases and controls. Finally, the
remaining two stars evaluate the comparability of the groups in terms of control for
potential confounders; for this report, one star was given to studies that controlled for age
and, additionally, for at least four of a predefined set of covariables (namely, family history
of BC, age at first birth or number of children, body mass index in postmenopausal women,
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hormone replacement therapy, and menopausal status), and a second star was rendered to
those studies that included at least five of these additional covariables: alcohol intake, oral
contraception, age at menarche, age at menopause, breastfeeding, physical activity, history
of benign breast disease, and education/socioeconomic status.
2.4. Statistical Methods
2.4.1. Meta-Analysis on Long-Term NSW and BC Risk
• Global meta-analysis of long-term NSW (for ≥15 years) and BC
We compared BC risk for women exposed to NSW for ≥15 years to that of unex-
posed women. We estimated summary risk ratios (RRs) and 95% confidence intervals
(CIs) as the measure of effect. Individual effect estimates were extracted to construct a
database with the logarithm of the risk estimator reported in each study (RR, hazard ratio
(HR), or odds ratio (OR)) and its standard error (SE). If SEs were not provided in the
publication, we calculated them from the CI, using the formula: SE = (lnCIupper limit-
lnCIlower limit)/(2 × 1.96). When the report provided different categories of exposure
but not an overall estimator, we calculated pooled RRs and variances using the formulas:
lnRR pooled = (lnRR1/Var1 + lnRR2/Var2 + lnRRn/Varn)/(1/Var1 + 1/Var2 + 1/Varn)
and Varpooled = 1/(1/Var1 + 1/Var2 + 1/Varn). The proportion of variance due to hetero-
geneity was estimated by the I2 statistic [34]. Heterogeneity between studies was assumed,
and a random-effects model was applied using the method of DerSimonian and Laird,
with the estimate of heterogeneity taken from the inverse-variance fixed-effects model.
To assess publication bias, funnel plot asymmetry was visually inspected and statisti-
cally tested with Begg’s and Egger’s tests (NFL, CS). We also carried out two sensitivity
analyses: (a) excluding those studies with uncertain exposure definition (see Figure S1)
and (b) restricting the analysis to those studies with NOS ≥ 7 (see Figure S2).
Program Codes Specific STATA© version 15 codes (metan, metafunnel, metabias) from
StataCorp. 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp
LLC were used for the meta-analysis and RevMan 5.4 test for differences in the predefined
subgroup analyses [35].
• Dose–response meta-analysis
For studies reporting disaggregated results by duration of NSW, we further conducted
a random-effects dose–response meta-analysis of log-relative risks (either adjusted log
hazard ratios for cohort studies or adjusted log odds ratios for case–control studies) on
mean durations of NSW for each exposure category [36]. The dose–response meta-analysis
was fitted through generalized least squares, which allowed for within-study correlations
among log-relative risks that used the same unexposed group as reference [37]. Linear
trends were allowed to vary randomly across studies, whose variance was estimated by
the method of moments [38]. We evaluated departures from the linear trend by including
a quadratic term for mean duration, as well as distinct linear trends in cohort, nested
case–control, and case–control studies by including interaction terms between mean du-
ration and study design indicators. The heterogeneity of log-relative risks with respect
to the pooled linear trend was contrasted with the Cochran chi-squared test and quanti-
fied with the I2 statistic, which described the proportion of total variation in log-relative
risks due to heterogeneity [34]. The dose–response meta-analysis was performed using
the glst command in Stata, version 14 from StataCorp. 2015. Stata Statistical Software:
Release 14. College Station, TX: StataCorp LP, and graphics were produced in R, version 3
(R Foundation for Statistical Computing).
• Subgroup meta-analysis by menopausal status
We stratified the overall analysis by menopausal status, which was preferentially based
on self-reported information. If this information was not available, given cut-off points
between age 50 and 55 were accepted to classify women either as pre- or as postmenopausal.
Again, a sensitivity analysis was performed, restricting the meta-analyses to those studies
with NOS ≥ 7.
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2.4.2. Meta-Analysis on Recent Long-Term NSW and BC
As the information on the timing of long-term NSW exposure was not readily available
in the selected studies, we used an indirect approach based on the analysis of BC before
retirement. We classified as having recent NSW those participants in the subgroup of
studies in which, either the mean age of the participants at study entry plus the maximum
follow-up time (cohort studies) or the mean age at BC diagnosis (case–control studies)
was below the country-specific retirement age in that year; this age was obtained from
the official government websites of each country or of the Organization for Economic
Co-operation and Development [39]. The meta-analysis was performed following the same
methodology that has been previously described.
3. Results
3.1. Search Results
The initial search yielded 1524 records found in PubMed, Embase, and Web of Science.
After the selection process, 16 articles with data from 18 research studies were finally
included in the global meta-analysis (Figure 1).
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Figure 1. Study flow diagram.
It is noteworthy to indicate that the early publications of the Nurses Health cohort
studies (NHS I and II) [20,40,41] were excluded from the main meta-analysis, due to the
availability of updated data with improved analyses from these projects, and that five
studies included in previous meta-analyses did not meet our inclusion criteria, as they did
not investigate long-term exposures (≥15 years of NSW) [28,42–45]. Our manual search
did not identify any additional articles.
3.2. Study Characteristics
Table 1 summarizes the main characteristics of the studies included in our global
meta-analysis, and the characteristics of other studies that did not meet our inclusion
criteria but that were included in previous reviews; this way, the reader may have a rapid
overview of the differences among the published meta-analyses in this area. In regard to
those studies fulfilling our crite i , eight re earch projects, published in six articles, had a
cohort design [12–14,22,46,47], five were nested case–control studies [17,18,21,48,49], and
five were case–control studies [15,16,19,50,51]. The numbers of participants and BC cases
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in the table correspond to the risk estimators used for the present global meta-analysis.
For risk estimators, all cohort studies reported HRs, except for one that reported RRs [20];
four of the five nested case–control studies reported ORs, and the remaining one reported
HR [48], while all case–control studies reported ORs. Regarding NSW exposure, it should
be noted that most of the studies only reported exposure status at baseline and did not
update this information; therefore, the real number of women who might have finally been
exposed to long-term NSW could be higher than reported, had we taken into account the
additional years of NSW during follow-up.
Table 2 provides further details on exposure characteristics for the studies selected in
this review, as well as indicates which are included in each of the meta-analyses presented
in this report. The table summarizes the definition of exposure and nonexposure in each
study. It should be noted that the operational approach used in several cases may raise
doubts about the accuracy of the classification [14,21,22,47]. Thus, in the two Nurses’
Health Studies [14], the definition for nonexposure was “never rotating NSW”, with
unclear classification for those women with permanent NSW. In another study among
Norwegian nurses [49], any woman working at infirmaries was classified as exposed to
NSW, while women working in managerial, teaching, physiotherapy, or at out-patients’
departments formed the nonexposed group. Additionally, in some reports only those with
current NSW and long-term stability at the same job (“job tenure”) [22] or with NSW in
the last 10 years [47], were considered as exposed, classifying as nonexposed those women
with former NSW exposure.
Concerning the timing of exposure ascertainment, in cohort studies, it was mostly
performed only at baseline, with just a few studies collecting data of additional years of
NSW during follow-up [14,47]. In nested case–control studies and case–control studies,
the ascertainment was retrospective, taking place after follow-up in the former and at
recruitment in the latter. Self-reporting was the most common source of information to
define NSW [12–19,47,49–51], while three studies [21,22,48] applied job-exposure matrices
(JEM) for this purpose. Interestingly, the Shanghai Women’s Health cohort study compared
both approaches, concluding that the use of JEM overestimated the prevalence of NSW [46].
As regards the duration of exposure, in 10 studies, the risk estimates provided by the
authors corresponded to NSW exposures of at least 20 years [12–15,17,22,47,48,50] and in
one study to exposures greater than 17 years [46].
3.3. Results of the Risk of Bias Assessment in the Selected Studies
The detailed risk of bias assessment for each selected study, according to the Newcastle–
Ottawa scale (NOS), is available in the Table S1. In summary, NOS scores ranged from
four [22] to eight stars [14,16,18]. Among cohort studies, the highest scores were obtained
by NHS I and II [14], penalized only by their focus on a single occupation. The other
cohort studies studied the general population, except for one, which included twins [13].
All but three cohort studies [22,28,46] achieved our highest quality criteria for control of
confounders. Only NHS I and II reported the proportion of participants lost to follow-up
for exposed and nonexposed groups and had a follow-up length over our threshold [14],
but two other cohort studies presented an overall number of losses to follow-up below
5% [46,47]. Three of the nested case–control studies received high scores in the NOS
(≥7) [17,18,49], and all case–control studies reached at least six points. The highest score
among them corresponded to a Canadian study [16], only penalized for not blinding the
interviewer, a common problem that often has a difficult logistic solution in this type
of study; in fact, only one case–control study used interviewers blinded to the disease
status [50]. The other common quality problem present in case–control-studies [15,19,50]
laid on differences in the response rate between cases and controls.
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Table 1. Main characteristics of studies included in this or in previous meta-analyses and pooled analyses on long-term NSW exposure and BC.
(a) Cohort Studies





































































10 yrsN 1 Ca 2 N 3 Ca 4
Schernhammer NHS
I (2001) [20] USA
Occup




(nurses) SR/HOSP 5804 427 31,746 2382 2809 max 24 <10% 8 – – – – – – – – – – X X
Schernhammer NHS
I and II (2014) [41] USA
Occup
(nurses) SR/HOSP max 22 <10% 8 – – – – X – – – – – –
Schernhammer
NHSII (2006) [40] USA
Occup




(nurses) SR/HOSP 162 35 43,529 950 985 max 24 <10% 8 – – – – – – – – – – X X
Pronk (2010) SWHS
based on JEM [46] 6
CHN Generalpop REG av 9.0 3% 6 X X – X X – – – – – – –
Ponk (2010) SWHS
based on SR [46] CHN
Working




pop REG av 12.4 n/a 6 – – – – X – – – – – – –
Koppes Dutch Labor
Force (2014) [22] NL
Working
pop REG n/a n/a 255,900 2312 n/a av 6.9 n/a 4 – – – – X X X – – – X –
Åkerstedt Salt Study
(2015) [13]








UK Generalpop REG 9647 89 450,232 4136 4225 av 2.6 n/a 7 – – – – – – X X – – X X
Jones Generations
Study (2019) [47] UK
General
pop REG n/a 60 84,888 1845 1905
median
9.5 4% 7 – – – – – – – – – – X X
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Table 1. Cont.
(b)Nested Case-Control and Case-Control Studies






























































10 yrsControls Cases Controls Cases
NESTED CASE–CONTROL STUDIES
Tynes (1996) [42] NOR Occup (ra-dio/tele) n/a REG 4–7:1 n/a n/a 5 – – X – – – – – – – – –
Lie (2006) [21] NOR Occup(nurses) IDS REG 4:1 417 125 n/a n/a 5 X – X – – – – – – – X X
Lie (2011) [49] NOR Occup(nurses) IDS REG 1.5:1 231 179 65 74 7 X X X X – – – – – – X X
Hansen (2012a) [17] DK Occup(nurses) IDS REG 4:1 124 39 91 92 7 X – X X – – – – – – X X
Hansen (2012b) [18] DK Occup(military) IDS REG 4:1 29 12 61 67 8 X X X X – – – – – – X X
Li (2015) [48] CHN Occup(textile) RND REG 2.8:1 n/a 576 n/a n/a 5 – – – – – – X X – – X X
CASE–CONTROL STUDIES












pop RND HOSP 1:1 76 79 6 – – X X – – – – X X – –
Fritschi (2013) [50] AUS Generalpop RND REG 1.5:1 53 84 41 58 7 – – – X – – – – X X X X
Grundy (2013) [16] CA BCscreening RND Mixed
7 1:1 53 65 V: 54,K: 49
V: 57
K:59 8 – – – X – – – – X X X X




pop RND HOSP 1:1 97 91 52 72 7 – – – – – – – – X X X X
Ascert (ascertainment), yrs (years), Q (quality index of the Newcastle–Ottawa scale; score range: 0–9), D-R (dose–response meta-analysis), Occup (occupational), SR (self-reported), SR/HOSP (self-
reported/hospital), max (maximum), SWHS (Shanghai Women’s Health Study), pop (population), REG (registry), av (average), n/a (not available), Ratio (ratio controls–cases), LT-NSW (long-term nightshift
work), radio/tele (radio/telegraph operators), IDS (incidence density sampling), RND (randomly), V (controls and cases from Vancouver), K (controls and cases from Kensington), CONSEC (consecutive)
1 Number of women exposed to ≥15 yrs of NSW. 2 BC cases among women exposed to ≥15 yrs of NSW. 3 Number of women not exposed to NSW. 4 Number of BC cases among women not exposed to NSW.
5 Total number of cases included in the present meta-analysis. 6 This study used a job-exposure matrix and self-reporting to ascertain NSW exposure. 7 Registry + BC screening.
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Table 2. Cont.
(b) Nested Case-Control and Case-Control Studies
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JEM 15–29 39.7 * 27–85 54 * (27–85) 61.7 67 [61] Still working X X X X
Lie (2011) [49] Rotating and permanent night work 3/m Never night work SR ≥15 n/a 20–70 54.5 (35–74) n/a 67 [61] Still working X – – X
Hansen (2012a)
[17]
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SR ≥20 54 * 31–69 n/a 56 65 [62] Still working *** X – – X
Hansen (2012b)
[18]
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Li (2015) [48]
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SR ≥20 54 (42–62) 2000–2004 65 [63] Still working X – – X
Fritschi (2013)
[50]
Worked any number of hours between
0.00 and 5 a.m. (graveyard shift) None
Never graveyard
shift SR ≥20 57 * (18–80) 2009–2011 64.5 [63] Still working X – – X
Grundy (2013)
[16]
Jobs that started/ended between 11
p.m. and 7 a.m. None
No yrs in jobs
with start or end
between 11 p.m.
and 7 a.m.
SR ≥15 57 (<80) 2005–2010 65 [39] Still working X X X X
Tsc (2014)
[51,55]









Partly/entirely working between 0 and
6 a.m. 3/m Never night work SR ≥15 56 (23–85) 2008–2013 65 [39] Still working X – – X
Min (minimum), freq (frequency), yrs (years), Retirement age (legal retirement age in the study country at the moment of the study), Premen (premenopausal), Postmen (postmenopausal), m (month), retro
(retrospective), SR (self-reported), NSWer (nightshift worker), Occ (occasionally), JEM (job-exposure matrix), n/a (not available), dx (diagnosis), yrs (years), expo ascert. (exposure ascertainment), dx (diagnosis),
grad (graduation). 1 May include permanent NSW. 2 Only the RR for premenopausal was included. 3 The first ten years of follow-up were included, as no NSW was assumed since 2009 by study authors. 4 No
jobs in the factory involved permanent NSW. 5 The BC risk for women < 50 years was included. 6 Kindly reported by e-mail from the author, * Calculated based on given categories of age or birth year; ** Median
age; *** Mean age at BC diagnosis was missing in this study, but the mean age at start of follow-up + years of full follow-up was under the retirement age.
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3.4. Results of the Meta-Analyses
3.4.1. Long-Term NSW and BC Risk
• Global meta-analysis on long-term NSW and BC risk
The meta-analysis of long-term NSW and BC risk (Figure 2) showed a global signifi-
cant increased risk of BC, although there was moderate heterogeneity of effects between
studies (pooled effect estimate = 1.13, 95%CI = 1.01–1.27, 18 studies, I2 = 56.8%, p = 0.002).
When we took into account study designs, the meta-analysis yielded no association be-
tween NSW and BC in cohort studies (pooled effect estimate = 1.04, 95%CI = 0.91–1.18,
I2 = 36.3%, p = 0.139); for nested case–control studies, it showed an almost significant risk in-
crease, although with high heterogeneity (pooled effect estimate = 1.34, 95%CI = 0.96–1.88,
I2 = 82.2%, p < 0.001); and, finally, in case–control studies, the pooled risk indicated an
excess risk of BC among exposed women (pooled effect estimate = 1.22, 95%CI = 1.01–1.48,
I2 = 0.0%, p = 0.613). We performed sensitivity analyses: (a) excluding the studies with
uncertain exposure definition, which showed similar results (pooled effect estimate = 1.17,
95%CI = 0.99–1.39, I2 = 61.8%, p = 0.002) (Figure S1); and (b) including only studies that
scored ≥7 stars at the NOS, which yielded the same overall risk estimate for long-term
NSW and BC (pooled effect estimate = 1.13, 95%CI = 1.00–1.28, I2 = 48.2%, p = 0.031)
(see Figure S2).




Figure 2. Forest plot of the meta-analysis on long-term nightshift work (≥15 years of NSW) and BC 
risk. 
The funnel plot to evaluate a possible relation between the RR of BC and the study 
precision showed an imbalance (Figure 3), which was statistically significant (Egger’s test 
p = 0.03, Begg’s test p = 0.08). The asymmetry was not present in a funnel plot limited to 
the high-quality studies (NOS ≥ 7) (see Figure S3) (Egger’s test p = 0.33, Begg’s test p = 
0.24). 
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• Dose–response meta-analysis 
The dose–response meta-analysis was based on 16 studies. Risk trends across 
categories of exposure duration varied substantially from one study to another, although 
Figure 2. Forest plot of the meta- n lysis on long-term nightshift work (≥15 years of NSW) and BC risk.
The funnel plot to evaluate a possible relation between the RR of BC and the study
precision show d an imbal nce (Figure 3), which was statistically significant (Egger’ test
p = 0.03, Begg’s test p = 0.08). The asymmetry was not present in a funnel plot limited to the
high-quality studies (NOS ≥ 7) (see Figure S3) (Egger’s test p = 0.33, Begg’s test p = 0.24).
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dose–response meta-analysis was based on 16 studies. Risk trends across ate-
gories of exposure duration varied substantially from one study o another, although most
of them tended to show an increase in risk with rising duration of NSW (Figure 4). The
pooled risk for BC increased by 4.7% for every 10 years of NSW duration (pooled effect
estimate = 1.05, 95%CI = 0.94–1.09), with moderate heterogeneity across studies (I2 = 33.4%,
p = 0.008), and no significant differences among cohort, nested case–control, and case–
control studies (p for interaction between exposure duration and study design = 0.45).
Adding a quadratic term to the model for exposure duration did not significantly improve
model fit (p = 0.389).
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significant increased risk for pre-/perimenopausal BC (pooled effect estimate = 1.27,
95%CI = 0.96–1.68, six studies, I2 = 32.0%, p = 0.196) (Figure 5), mostly due to the re-
sults of cohort studies, while no association was found for postmenopausal BC (pooled
effect estimate = 1.05, 95%CI = 0.90–1.24, seven studies, I2 = 52.4%, p = 0.050) (Figure 6),
although the test for subgroup differences was not significant (p = 0.27). However, in
our sensitivity analysis, restricted to high-quality studies, the difference between both
subgroups was more marked (pooled effect estimate premenopause = 1.57; 95%: 1.11–2.21;
pooled effect estimate postmenopausee = 1.08; 95%: 0.94–1.24; test for subgroup differences:
p = 0.05) (see Figures S4 and S5).
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3.4.2. Recent Long-Term NSW and BC Risk
This last meta-analysis included data from 15 studies. Among them, data from the
NHS1 after 10 years of follow-up could be included, as the biological age of menopause
normally is below the retirement age of 65 years [20]. The updated HRs for women from
the NHS2 after 10 years of follow-up [14] and the HRs for women Shanghai textile workers
under 50 years [48] could also be included. Moreover, we included a Danish nested case–
control study [17], which provided mean age at the beginning of the study, and the sum
of the years of follow-up resulted in ages below the retirement age in Denmark at that
time. The meta-analysis of recent long-term NSW and BC showed a significant pooled risk
of BC of around 23% (95%CI = 1.06–1.42), with moderate heterogeneity between studies
(I2 = 48.4%, p = 0.018) (Figure 7) (test of interaction between NSW and BC before and after
retirement: p = 0.001). The results were similar in all study design groups (20% for cohort
studies, 95%CI = 0.88–1.65, 29% for nested case–control studies, 95%CI = 0.96–1.73, and
22% for case–control studies, 95%CI = 1.01–1.48).
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Table 3 shows the main su ary effect esti ates of previous eta-analyses, dose–
response eta-analyses, and sub-meta-analyses for the association between long-term
NSW and BC risk, globally and in pre- and postmenopausal women, to allow the reader to
have a better perspective of the results that have been published in this matter.
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Table 3. Summary results of the meta-analyses, dose-response meta-analyses and sub-meta-analyses for the association




































































































4.1. The Association between Long-Term NSW and BC Risk
The global meta-analysis showed that the risk of BC in women exposed to ≥15 years of
NSW is 13% higher than that of those who had not worked nightshifts, although there was
moderate heterogeneity among the studies. In the dose–response meta-analysis, the BC risk
increased by 4.7% for every 10 years of exposure to NSW. The analysis by menopausal status
suggested that this association was limited to premenopausal BC, while no association was
observed for BC risk after menopause; this difference was quite more marked when we
restricted the analysis to high-quality studies. We also found an excess of risk among those
women exposed to recent long-term NSW, but due to the scarcity of studies, we did not
evaluate differences by menopausal status in this subgroup. It should be noted that the use
of aggregated data on age and retirement as a proxy for recent exposure, due to the lack of
individual information, renders it very difficult to separate the possible effects of the time
lag (between exposure cessation and outcome) from those of menopausal status and age.
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4.2. Comparison with Former Meta-Analyses and Relevant Studies
Our global findings are similar to the results of a meta-analysis carried out by
Jia et al. [10], who reported a 15% increased BC risk for long-term NSW. Additionally,
He et al. [54] found a 6% increased BC risk for every 10 years of exposure in their dose–
response meta-analysis, similar to our result. Considering only the results from cohort
studies, our pooled estimate was comparable with the null results of previous meta-
analyses [12,54], while another one detected an 8.8% risk increase after 20 years of NSW
exposure [11]. For premenopausal BC and long-term NSW, we found a slightly lower
increased risk than the one reported by Cordina-Duverger et al. [30] for an exposure of at
least twenty years after pooling the results of case–control studies, though in that study, no
elevated risk was observed for exposure durations between 10 and 20 years. As this review
includes, to our knowledge, the first intent of carrying out a sub-meta-analysis of BC risk
before retirement and long-term NSW, we could not compare the results related to recent
NSW exposure.
4.3. Interpretation of the Results and Possible Mechanisms of the Association
Our analyses of long-term NSW suggest that this exposure was associated with BC
before retirement or menopause. It is conceivable that, during regular NSW exposure,
changes in sex hormone secretion [65] or other biological mechanisms might drive the
growth of malignant tumor cells with a promoter effect; if that were the case, once exposure
ceases, the BC risk might drop to normal levels. Similar effects had been proposed for
the action of hormone replacement therapy [66] but were later partly questioned by a
meta-analysis [67]. Alternatively, some cancer-relevant epigenetic, genetic, or microenvi-
ronmental changes caused or favored by long-term NSW might contribute to transforming
breast epithelial cells into malignant cells before menopause, supported by the higher cell
proliferation rates at this stage [68]. It is also plausible that the NSW-related risks persist
during more years, but cumulative DNA damage with age, caused by a wide spectrum
of reasons [69], could mask the deleterious effects of NSW in older women. In regard to
long-term NSW, having been working in night shifts for at least 15 years makes it more
likely to be exposed in windows of increased susceptibility, that is, in life periods during
which harmful factors can more easily lead to cancer. One of these susceptibility periods is
the time before a first birth [70]. The early life etiological model of BC [70] suggests that
childbirth and breastfeeding cause differentiation of mammary stem cells so that they are
consequently less prone to proliferate and cause BC. Thus, NSW exposure after the first
childbirth is expected to be less harmful than before this life event. However, the few risk
estimates for NSW exposure before the first childbirth found in the literature are contradic-
tory [19,45,50]. Menopausal transition might also be a period of higher susceptibility [71],
but unfortunately, the impact of NSW during this susceptibility window has not been
studied yet.
4.4. Strengths and Limitations
The exhaustive literature search, including studies published up to December 2020,
allowed us to provide updated estimates of risk associated with long-term NSW, as well as
to perform an updated dose–response meta-analysis. In contrast to a previously published
report [30], we included cohort, nested case–control, and case–control studies. For this
review, we assessed the risk of bias of included studies and carried out a sensitivity analysis
based on their quality scores. Additionally, we explored the consistency of our results after
excluding those studies with uncertain exposure definitions or ascertainment. However,
probably, the major strength of this meta-analysis resides in its deeper analysis of the risk
for long-term NSW, thanks to the sub-meta-analyses carried out by menopausal status, a
factor involved in clinical and epidemiological differences in BC, and by recent exposures,
which allow exploring the hypothesis under debate of a reduction of risk after the cessation
of NSW exposure. Noteworthy, the subgroup analysis by menopausal status was mainly
based on within studies comparisons. Our approach on recent long-term NSW, even
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with its mentioned limitations, represents an original analysis trying to overcome the
scarcity of information about time since NSW cessation. Although we are not able in this
review to decipher the reasons for the association found between long-term NSW and
breast cancer during working age, we think it is an interesting new finding that deserves
further investigation.
Notwithstanding, this review also has limitations. The asymmetry of the funnel plot
may suggest that our estimates can be affected by publication bias or by differences in
the quality of smaller studies that may spuriously inflate their effects [72]. However, our
sensitivity analysis, restricted to the studies of higher methodological quality (NOS ≥ 7),
yielded the same overall risk as the global meta-analysis, while asymmetry, according to
the funnel plot and the Egg test, was no longer significant. Another limitation comes from
the heterogeneity observed in the meta-analysis. As previously mentioned, we explored
several putative factors that might contribute to explaining it (e.g., study design and study
quality, menopause, exposure definition); however, other design characteristics, such as
NSW pattern (e.g., permanent versus rotating shift work or frequency of shifts) or NSW
assessment (i.e., self-report versus JEM), may also contribute to it. It has been described
that self-report can be used as a reliable method for NSW exposure [73], while, in contrast,
JEM might result in misclassification bias towards the null [46]. As the three included
studies [21,22,48] that used JEMs received high weights in the meta-analysis (in total 23%),
it is possible that we might be underestimating the risk due to NSW. The distribution of
BC molecular subtypes might also differ among studies, being an additional uncontrolled
potential source of heterogeneity, although it is not yet known whether NSW may have a
different role in the pathogenesis of BC per subtype. Cordina-Duverger recently described
higher risks of NSW linked to tumors that were both HER+ and ER+ [30]. Finally, we could
only carry out an indirect approach to the risk associated with recent long-term NSW. This
approach assumes that NSW is current or recent if the woman—really, the mean age of the
participants—has not reached retirement age. However, we do not have data to test this
assumption, which surely includes a certain misclassification. Additionally, it is difficult to
disentangle the effect of menopause, as both are age related.
5. Conclusions
Our meta-analysis supports the hypothesis that long-term NSW is a risk factor for BC.
Even though the possible effect of the publication bias is small, we prudently classify the
evidence as low. Among the factors that may modify this risk, which are possible sources
of the observed heterogeneity, are menopause and time since last NSW exposure. Both
factors point towards higher risks in younger women. In contrast, no association was
found between long-term NSW and BC in postmenopausal women. Future investigators
on NSW and this tumor should also take into consideration the timing of exposure and the
menopausal status at BC diagnosis.
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to studies of high quality (NOS ≥ 7), Figure S5: Analysis of long-term NSW and postmenopausal
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